e-Motion : Promoting Emotion Regulation in Chronic Cancer
The present study aimed to pilot evaluate two interventions: a Guided Self-Help Intervention alone, and a combined Group and Guided Self-Help Intervention, designed to support individuals living with chronic cancer and recently diagnosed. The primary aim of this pilot study is to assess the feasibility, acceptability a
| Condition(s) | Metastatic Cancers, Myeloma Multiple |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The present study aimed to pilot evaluate two interventions: a Guided Self-Help Intervention alone, and a combined Group and Guided Self-Help Intervention, designed to support individuals living with chronic cancer and recently diagnosed. The primary aim of this pilot study is to assess the feasibility, acceptability and tolerability of the interventions. The secondary aim of the pilot study is to assess the interventions preliminary efficacy and differences on psychological symptoms. |
| Who can participate | Inclusion Criteria: * Having received a diagnosis of chronic cancer (metastatic breast cancer, metastatic melanoma, metastatic colorectal, metastatic ovarian, metastatic uterine, metastatic endometrial, metastatic prostate, metastatic bladder, metastatic kidney or metastatic testicular cancer, symptomatic multiple myeloma, metastatic non-small cell lung, metastatic mesothelioma or metastatic thymoma) in the past 12 months, * Having completed at least one active treatment session (e.g., chemotherapy, surgery, radiotherapy, immunotherapy, target therapy). Exclusion Criteria: * Having less than one year of life expectancy * Having more than one treatment line (for triple negative breast cancer, melanoma, gynecological cancer, colorectal cancer, bladder cancer, kidney cancer, non-small cell lu |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Université Libre de Bruxelles |
| Locations | Brussels, Anderlecht, Belgium; Brussels, Brussels Capital, Belgium |
| Start date | 2025-11-20 |
| NCT ID | NCT07236021 |
| Official listing | https://clinicaltrials.gov/study/NCT07236021 |